Get the Stockscreener App
3.55
940.45%
3.2088
After Hours:
3.33
-0.22
-6.20%
Collplant Biotechnologies Ltd stock is traded at $3.55, with a volume of 236.15K.
It is up +940.45% in the last 24 hours and up +1,138% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$0.3412
Open:
$3.31
24h Volume:
236.15K
Relative Volume:
0.08
Market Cap:
$67.12M
Revenue:
$389.00K
Net Income/Loss:
$-13.13M
P/E Ratio:
-3.4389
EPS:
-1.0323
Net Cash Flow:
$-11.90M
1W Performance:
+891.62%
1M Performance:
+1,138%
6M Performance:
+463.49%
1Y Performance:
+36.15%
1-Day Range:
$2.99
$3.91
1-Week Range:
$0.2912
$3.91
52-Week Range:
$0.2637
$3.91
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
3.55 | 6.01M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition - TipRanks
CollPlant Biotechnologies LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
CollPlant adds LightSolver CEO Dr. Ruti Ben Shl... - Pluang
A physicist who helped create light-based computing joins CollPlant's board - Stock Titan
CollPlant Finalizes LightSolver Acquisition with $5 Million Equity Investment - Kalkine Media
CollPlant (CLGN) moves into photonic computing with LightSolver acquisition - Stock Titan
CLGN Looks 14.7% Overvalued on GF Value™ - GuruFocus
collplant completes acquisition of lightsolver, entering the photonic computing sector - fidelity.com
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - Yahoo Finance
CollPlant Biotechnologies acquires laser-based computing startup LightSolver - datacenterdynamics.com
CollPlant to Implement 1-for-10 Reverse Stock Split - marketscreener.com
CLGN Looks 24.2% Overvalued on GF Value™ - GuruFocus
Reverse split ahead for CollPlant (NASDAQ: CLGN) to help keep its Nasdaq listing - Stock Titan
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PR Newswire
CollPlant to acquire LightSolver in photonic computing deal - Engineering.com
CollPlant Buys LightSolver in Bet on Laser-Based Computing - finance.biggo.com
CollPlant Biotechnologies Ltd. signed a definitive agreement to acquire Lightsolver Ltd. for $84.2 million. - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
CollPlant agrees LightSolver photonic computing deal - grafa.com
Why CollPlant Biotechnologies (CLGN) Stock Is Up Today - Quiver Quantitative
CollPlant Acquires LightSolver, Enters Supercomputing and Photonic Computing Markets - HPCwire
CollPlant to Acquire LightSolver, Pivoting Into Photonic Supercomputing - TipRanks
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PH - GuruFocus
CollPlant Biotechnologies (NASDAQ: CLGN) files foreign issuer update - Stock Titan
CollPlant To Acquire LightSolver As Laser Processing Unit Targets 2028 Commercial Launch - pulse2.com
CLGN Looks 14.5% Overvalued on GF Value™ - GuruFocus
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS - PR Newswire
Press Release: COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS - 富途牛牛
Inside Loewenbaum's capped warrant-backed bet on CollPlant (CLGN) - Stock Titan
Bioink Market Set to Booming Growth 2026-2033 | CELLINK, - openPR.com
What Could CollPlant (NASDAQ:CLGN) Results Signal for Investors? - Kalkine Media
CollPlant (CLGN) Financial Update: The Available Earnings Metric Delivers a Miss for the Current Session; Shares Move Lower 1.66% in the Available RecordProfit Announcement - vinanet.vn
CollPlant Shareholders Approve All Proposals at August 18 Extraordinary Meeting - TipRanks
CollPlant (CLGN) shareholders back both August EGM items - Stock Titan
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue R&D PushPre-Earnings Drift - vinanet.vn
CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks
CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan
CLGN Q4 2025 Earnings: Wider-Than-Expected Loss Pressures Shares as R&D Investment ContinuesTrough Earnings Signal - vinanet.vn
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares Down 9%CFO Commentary Report - vinanet.vn
Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan
CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - theglobeandmail.com
CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.327|Chg%:+0.012 - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.312|Chg%:+0.040 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Cash Flow - TradingKey
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):